# Regeneron Is Filing for Approval of a Deafness Gene Therapy. Then Comes the Hard Debate.

- slug: regeneron-is-filing-for-approval-of-a-deafness-gene-therapy-then-comes-the-hard-debate
- date: 2026-04-22
- category: Biotech & Life Sciences

Regeneron is moving toward FDA approval for a gene therapy that restored hearing in all ten patients in a China trial — nine of ten children in its own study. The filing puts cochlear implant debates back on the table, and the durability data is only six months deep.

---